Πέμπτη 19 Απριλίου 2018

Plasma immunoprofiling of patients with high-risk diffuse large B-cell lymphoma: a Nordic Lymphoma Group study.

http:--www.nature.com-images-lo_npg.gif https:--www.ncbi.nlm.nih.gov-corehtml-pm Related Articles

Plasma immunoprofiling of patients with high-risk diffuse large B-cell lymphoma: a Nordic Lymphoma Group study.

Blood Cancer J. 2016 11 18;6(11):e501

Authors: Pauly F, Fjordén K, Leppä S, Holte H, Björkholm M, Fluge Ø, Møller Pedersen L, Eriksson M, Isinger-Ekstrand A, Borrebaeck CA, Jerkeman M, Wingren C

PMID: 27858932 [PubMed - indexed for MEDLINE]



https://ift.tt/2EYOxt9

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου